Clarke To Oversee Glaxo Consumer Division During Xenical Switch Bid
This article was originally published in The Tan Sheet
Executive Summary
Glaxo's plan to switch Xenical (orlistat 60 mg) to over-the-counter status for adults only "provides difficulties in the ultimate marketing," incoming Consumer Healthcare president John Clarke allowed